Crigler Najjar Disease
At a Glance
Crigler Najjar disease is a genetic abnormality that results in a persistent elevation of total bilirubin.
What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?
Elevated total bilirubin
Elevated indirect (unconjugated) bilirubin
No evidence of hemolysis related process
Type 1 markedly elevated persistent levels of total bilirubin manifesting in the newborn
Type 2 manifests later in life with less markedly elevated levels of total bilirubin
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Coffee and Cancer
- Upfront Next-Generation Sequencing Is Faster, More Cost Effective in Metastatic NSCLC
- In Melanoma, Older Adults Could Benefit More From Treatment With PD-1 Inhibitors
- Pembrolizumab FDA-Approved for the Treatment of Advanced Cervical Cancer
- Postoperative Radioactive Iodine Ablation Effective in Reducing Disease Recurrence in Low-Risk Thyroid Cancer
- ARID1A Mutations Might Predict Tumor Response to Immunotherapy
- High Tissue Tumor Mutational Burden May Be Predictive of Improved Immunotherapy Efficacy
- Adding Oxaliplatin to Capecitabine-Based Chemotherapy, Radiation May Not Improve Survival in Rectal Cancer